Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ambarella surges after report says company exploring strategic options, including sale (SeekingAlpha) +++ AMBARELLA Aktie +15,53%

XOMA ROYALTY Aktie

 >XOMA ROYALTY Aktienkurs 
22.6 EUR    +0.0%    (Tradegate)
Ask: 24.2 EUR / 300 Stück
Bid: 23.8 EUR / 300 Stück
Tagesumsatz: 1 Stück
Realtime Kurs von 8 bis 22 Uhr!
XOMA ROYALTY Aktie über LYNX handeln
>XOMA ROYALTY Performance
1 Woche: +1,0%
1 Monat: -2,3%
3 Monate: +10,1%
6 Monate: -17,8%
1 Jahr: -8,2%
laufendes Jahr: -13,8%
>XOMA ROYALTY Aktie
Name:  XOMA ROYALTY
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US98419J2069 / A2ATUH
Symbol/ Ticker:  X0M1 (Frankfurt) / XOMA (NASDAQ)
Kürzel:  FRA:X0M1, ETR:X0M1, X0M1:GR, NASDAQ:XOMA
Index:  -
Webseite:  https://www.xoma.com/
Marktkapitalisierung:  246.06 Mio. EUR
Umsatz:  36.97 Mio. EUR
EBITDA:  -19.54 Mio. EUR
Gewinn je Aktie:  -0.543 EUR
Schulden:  98.61 Mio. EUR
Liquide Mittel:  79.83 Mio. EUR
Umsatz-/ Gewinnwachstum:  967.9% / -
KGV/ KGV lG:  - / 85.47
KUV/ KBV/ PEG:  24.27 / 3.38 / -
Gewinnm./ Eigenkapitalr.:  -6.66% / -3.42%
Dividende je Aktie:  0.525 EUR
Dividendenrendite/ -schätzung:  2.6% / 8.71%
Div. Historie:  03.01.25 - 0.52504€
02.04.24 - 0.5003€
Insiderhandel:  -
Suchwörter:  XOMA ROYALTY
Letzte Datenerhebung:  24.06.25
>XOMA ROYALTY Eigentümer
Aktien: 11.97 Mio. St.
f.h. Aktien: 9.24 Mio. St.
Insider Eigner: 0.94%
Instit. Eigner: 62.68%
>XOMA ROYALTY Peer Group

 
18.06.25 - 13:36
XOMA Royalty Declares Quarterly Preferred Stock Dividends (GlobeNewswire EN)
 
EMERYVILLE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty's Series A and Series B Cumulative Preferred Stock:...
27.05.25 - 14:51
XOMA Royalty purchases mezagitamab royalty rights from BioInvent International for $30M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.05.25 - 07:01
Insiderhandel: Chief Executive Officer verkauft Aktien von XOMA im Wert von 650667 USD (Insiderkauf)
 
Hughes, Owen - Vorstand - Tag der Transaktion: 2025-05-20...
22.05.25 - 07:01
Insiderhandel: SVP, Finance & CFO verkauft Aktien von XOMA im Wert von 266033 USD (Insiderkauf)
 
Burns, Thomas M. - Vorstand - Tag der Transaktion: 2025-05-20...
21.05.25 - 05:02
Insiderhandel: Insider verkauft Aktien von XOMA im Wert von 10642794 USD (Insiderkauf)
 
Bvf, Partners L P. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2025-05-16...
14.05.25 - 08:36
Xoma Reports Strong Water Test Results at Boliden Rönnskär – Negotiations on Next Steps Initiated (Cision)
 
Xoma AB is now able to present the results from initial water samples taken at Boliden's facility in Rönnskär. The tests demonstrate that Xoma's microalgae-based purification technology, FLOW, effectively reduces the concentrations of several heavy metals in process water. Particularly promising is the reduction of arsenic, which is typically very difficult to remove. The analyses were carried out and validated by Umeå University and show the following removal efficiencies: [En bild som visar text, skärmbild, diagram, Rektangel AI-genererat innehåll kan vara felaktigt.] These...
13.05.25 - 13:48
XOMA Royalty GAAP EPS of $0.06, revenue of $15.91M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.25 - 13:33
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference (GlobeNewswire EN)
 
EMERYVILLE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad Sitko, will be featured speakers at the H.C. Wainwright 1st Annual Royalty Company Virtual Conference being held May 13, 2025....
28.04.25 - 09:24
SVT Highlights Xoma′s collaboration with Umeå University (Cision)
 
Groundbreaking Research on Microalgae In a recently published article from SVT Nyheter, the groundbreaking research led by Christiane Funk at Umeå University is highlighted. The research explores the potential of microalgae as the "waste management workers" of the future. The research team has demonstrated that local microalgae can purify industrial wastewater by removing heavy metals such as cadmium and arsenic. Collaboration with Umeå University Xoma AB is proud to actively contribute to this important research project through a collaboration with Umeå University. As part of the...
14.04.25 - 13:33
XOMA Royalty Completes Sale of Kinnate Pipeline Assets (GlobeNewswire EN)
 
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens...
10.04.25 - 01:01
Insiderhandel: Chief Investment Officer kauft Aktien von XOMA im Wert von 49400 USD (Insiderkauf)
 
Sitko, Bradley - Vorstand - Tag der Transaktion: 2025-04-07...
08.04.25 - 05:01
Insiderhandel: Aufsichtsrat kauft Aktien von XOMA im Wert von 173293 USD (Insiderkauf)
 
Limber, Joseph M. - Aufsichtsrat - Tag der Transaktion: 2025-04-04...
08.04.25 - 05:01
Insiderhandel: Aufsichtsrat kauft Aktien von XOMA im Wert von 134221 USD (Insiderkauf)
 
Limber, Joseph M. - Aufsichtsrat - Tag der Transaktion: 2025-04-07...
08.04.25 - 05:01
Insiderhandel: Aufsichtsrat kauft Aktien von XOMA im Wert von 452631 USD (Insiderkauf)
 
Limber, Joseph M. - Aufsichtsrat - Tag der Transaktion: 2025-04-03...
03.04.25 - 01:01
Insiderhandel: Chief Investment Officer kauft Aktien von XOMA im Wert von 26201 USD (Insiderkauf)
 
Sitko, Bradley - Vorstand - Tag der Transaktion: 2025-03-31...
03.04.25 - 01:01
Insiderhandel: SVP, Finance & CFO kauft Aktien von XOMA im Wert von 25460 USD (Insiderkauf)
 
Burns, Thomas M. - Vorstand - Tag der Transaktion: 2025-04-01...
02.04.25 - 13:33
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference (GlobeNewswire EN)
 
EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a featured presenter at the Jones Healthcare and Technology Innovation Conference being held April 8-9, 2025....
26.03.25 - 01:01
Insiderhandel: Chief Investment Officer kauft Aktien von XOMA im Wert von 98751 USD (Insiderkauf)
 
Sitko, Bradley - Vorstand - Tag der Transaktion: 2025-03-21...
21.03.25 - 09:00
Xoma AB and Arctic Roe of Scandinavia AB Sign Letter of Intent (LOI) for the Development of Vegetarian Caviar (Cision)
 
Xoma AB ("Xoma") and Arctic Roe of Scandinavia AB ("Arctic Roe") have signed a Letter of Intent (LOI) to explore the possibility of developing a vegetarian caviar, produced in the forests of Småland, over the next six months. [image]As a first phase of the collaboration, Xoma, through its test facility, will supply algae to Arctic Roe. The goal is for Arctic Roe to develop a vegetarian caviar that meets their high-quality standards and can be tested by their exclusive customer base. This caviar will be developed from our exclusive Caulerpa and will become a vegetarian caviar that...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Was man zu lang bedenkt, das wird bedenklich. - Sprichwort
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!